Published in Oncogene on November 28, 2002
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A (2007) 4.04
Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci U S A (2012) 1.79
DNA microarrays: a powerful genomic tool for biomedical and clinical research. Mol Med (2007) 1.38
Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells. Cancer Res (2010) 1.23
Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol (2007) 1.22
In praise of arrays. Pediatr Nephrol (2008) 0.91
A role for Drosophila in understanding drug-induced cytotoxicity and teratogenesis. Cytotechnology (2008) 0.77
Determining signalling nodes for apoptosis by a genetic high-throughput screen. PLoS One (2011) 0.77
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther (2008) 10.35
Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol (2009) 2.55
A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell (2012) 2.29
Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci (2003) 2.03
Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure (2006) 1.92
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci (2006) 1.89
Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization. FEBS J (2007) 1.14
Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD). PLoS Genet (2013) 1.00
Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt. Biochim Biophys Acta (2011) 0.99
New molecules from old classes: revisiting the development of beta-lactams. IDrugs (2009) 0.97
The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells. Biochem Pharmacol (2010) 0.97
Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther (2006) 0.94
Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro. Br J Pharmacol (2010) 0.90
Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol (2002) 0.89
In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs. Antimicrob Agents Chemother (2009) 0.89
Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy. Biochem Pharmacol (2009) 0.88
Bioinformatics prediction of overlapping frameshifted translation products in mammalian transcripts. BMC Genomics (2008) 0.87
Second-site NMR screening and linker design. Curr Top Med Chem (2003) 0.84
Hepatocellular toxicity of clopidogrel: mechanisms and risk factors. Free Radic Biol Med (2013) 0.83
FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis. J Mol Cell Biol (2013) 0.81
Yeast synthetic biology platform generates novel chemical structures as scaffolds for drug discovery. ACS Synth Biol (2014) 0.79
Comparison of variability and sensitivity between nuclear translocation and luciferase reporter gene assays. J Biomol Screen (2009) 0.79
Toxicity of clopidogrel and ticlopidine on human myeloid progenitor cells: importance of metabolites. Toxicology (2012) 0.77
Toxicity of thienopyridines on human neutrophil granulocytes and lymphocytes. Toxicology (2013) 0.75